Eli Lilly launches new weight loss pill

Eli Lilly has officially launched its new weight-loss medication, Foundayo, in the United States market. This launch introduces a new therapeutic option for individuals seeking to manage their weight. The availability of Foundayo is expected to be closely watched by healthcare providers, patients, and competitors within the pharmaceutical industry. Further details on its efficacy, side effects, and market reception will emerge as it becomes more widely prescribed.